VetSheet

雌三醇

Estriol

Oestriol

荷爾蒙 - 雌激素PO

別名: Incurin · Oestriol

由 VetSheet 獸醫團隊審訂更新於 2026年4月5日本內容以實證獸醫文獻為本

Starting dose: 1 mg/dog. If successful, reduce to 0.5 mg/dog. If unsuccessful, increase to 2 mg/dog. Minimum effective dose: 0.5 mg/dog. Maximum dose: 2 mg/dog.PO· q24h (can consider q48h for maintenance once response is seen)· Long-term
1 mg 每隻動物的固定劑量(不按體重換算)

劑量為合格獸醫專業人員的臨床參考。請務必對照最新仿單及個別病患確認。

各物種劑量

🌎 NA — North America🌍 EU — Europe

適應症劑量途徑頻次療程地區
Urethral sphincter mechanism incompetence (USMI) in spayed bitchesStarting dose: 1 mg/dog. If successful, reduce to 0.5 mg/dog. If unsuccessful, increase to 2 mg/dog. Minimum effective dose: 0.5 mg/dog. Maximum dose: 2 mg/dog.POq24h (can consider q48h for maintenance once response is seen)Long-term🌍 EU
  • Urethral sphincter mechanism incompetence (USMI) in spayed bitches: Alternate-day dosing can be considered once a response has been seen.

適應症劑量途徑頻次療程地區
All indicationsDo not use.PON/AN/A🌍 EU
  • All indications: Contraindicated or not recommended for use in cats.

劑量為合格獸醫專業人員的臨床參考。請務必對照最新仿單及個別病患確認。

正在看診?VetSheet 的 AI 會把藥物、劑量與療程直接寫入結構化的看診紀錄。了解 VetSheet 如何運作

概覽

雌三醇是一種短效的合成雌激素,對下泌尿生殖道的雌激素受體具有高親和力。主要用於治療已絕育母犬的尿道括約肌機能不全 (USMI)。

作用機轉

Estriol binds to estrogen receptors in the lower urogenital tract → increases resting urethral muscle tone and mucosal vascularity → improves urodynamic function and urethral closure pressure.

安全性與警告

禁忌症

  • Intact bitches
  • Polyuria/polydipsia (PU/PD) of unknown origin
  • Animals < 1 year old

不良反應

  • Oestrogenic effects (swollen vulva, attractiveness to males) in 5-9% of dogs at 2 mg/day
  • Bone marrow suppression (rare, but possible with long-term use)
  • Gastrointestinal upset (mild)

注意事項

​Human Safety Warning:​ Pregnant or breastfeeding women should handle this medication with caution. Wash hands after administration or wear gloves.

藥物交互作用

PhenylpropanolamineMinor

Concurrent administration may potentiate efficacy in treating urinary incontinence (synergistic effect).

監測

  • Clinical response (resolution of urinary incontinence)
  • Complete Blood Count (CBC) periodically for long-term use to monitor for bone marrow suppression
  • Signs of estrogenic side effects (vulvar swelling)

藥物動力學

半衰期

Short-acting

吸收

Rapidly absorbed from the gastrointestinal tract after oral administration.

分佈

Widely distributed, with high affinity for estrogen receptors in the urogenital tract.

代謝

Undergoes hepatic metabolism and enterohepatic recirculation.

排除

Excreted primarily in the urine as conjugates.

過量

Overdose may lead to exaggerated estrogenic effects, including pronounced vulvar swelling, attractiveness to male dogs, and potentially an increased risk of bone marrow suppression (anemia, thrombocytopenia, leukopenia). Treatment is supportive and symptomatic; discontinue the drug until signs resolve.

可用產品

劑型

  • 1 mg oral tablet

獸醫用

  • Incurin 1 mg tablets

人用標示

  • Ovestin (various strengths, creams/tablets)

各地核准狀態

United States✓ 已核准處方藥FDA/CVM
🐕 Dogs

Approved for control of estrogen-responsive urinary incontinence in ovariohysterectomized dogs.

European Union✓ 已核准處方藥EMA
🐕 Dogs

POM-V classification.

United Kingdom✓ 已核准處方藥VMD
🐕 Dogs

POM-V classification.

暫無法規資料: 🇭🇰 HK · 🇹🇼 TW · 🇯🇵 JP · 🇰🇷 KR · 🇦🇺 AU

儲存與穩定性

Store at room temperature in a dry place, protected from light. Keep out of reach of children and animals.

飼主須知

請按照獸醫的指示給藥。

​警告:​ 懷孕或哺乳期婦女在接觸此藥物時應謹慎(建議戴手套或接觸後洗手)。

請觀察您的狗是否有發情跡象(外陰腫脹、吸引公狗),如有請告知獸醫。請勿超過處方劑量。

VetSheet 藥物參考供合格獸醫專業人員作臨床決策輔助之用,不能取代專業判斷或廠商最新仿單。